M

Mira Pharmaceuticals, Inc.

0 followers

MIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects, such as increased appetite and paranoia.

Employees

11-50

Links


Org chart

Erez Aminov's profile picture
Erez Aminov
Executive Chairman & CEO
Profile photo

Erez Aminov

Collapse
Michelle Yanez, MBA
Chief Financial Officer

Teams

This company has no teams yet

Offices